Search

Search Constraints

You searched for: Author/Creator Rosenbaum, Cara A.

Search Results

2. Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma. (24th May 2019)

3. Phase 2 multicentre study of single‐agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance). (5th February 2019)

5. Twice‐weekly ixazomib in combination with lenalidomide‐dexamethasone in patients with newly diagnosed multiple myeloma. (25th June 2018)